We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

August 23, 2017

MITSUBISHI TANABE PHARMA CORPORATION et al v. INVAGEN PHARMACEUTICALS, INC.,

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 24, 2017

    InvaGen Infringed Diabetes Drug Patent, Pharma Cos. Say

    Pharmaceutical companies Mitsubishi Tanabe Pharma Corp., Janssen Pharmaceuticals Inc. and Cilag GmbH International on Wednesday accused InvaGen Pharmaceuticals Inc. of infringing a patent by attempting to get approval to sell a generic version of Janssen’s diabetes treatment Invokamet.


Parties

To view the parties, register now.